For the diagnosis of early Alzheimer’s disease (AD), the in vivo PET imaging of characteristic pathological features aggregated amyloid protein (Aβ) and neurofibrillary tangle (tau) by using dedicated radiopharmaceuticals has been recognized as potentially having an important role [6]. The gene discussed is MAPT; the disease is Alzheimer disease.